Recent advances of miRNAs in the development and clinical application of gastric cancer.

VernacularTitle:Recent advances of miRNAs in the development and clinical application of gastric cancer
Author: Si-Ran WU ¹ ; Qiong WU ² ; Yong-Quan SHI ¹
Author Information

1. State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases, Xijing Hospital, Air Force Military Medical University, Xi'an, Shaanxi 710032, China.
2. Department of Clinical Nutrition, Xijing Hospital, Air Force Military Medical University, Xi'an, Shaanxi 710032, China.
Publication Type:Journal Article
From: Chinese Medical Journal 2020;133(15):1856-1867
CountryChina
Language:English
Abstract: Gastric cancer (GC) is one of the most common malignant tumors. The mechanism of how GC develops is vague, and therapies are inefficient. The function of microRNAs (miRNAs) in tumorigenesis has attracted the attention from many scientists. During the development of GC, miRNAs function in the regulation of different phenotypes, such as proliferation, apoptosis, invasion and metastasis, drug sensitivity and resistance, and stem-cell-like properties. MiRNAs were evaluated for use in diagnostic and prognostic predictions and exhibited considerable accuracy. Although many problems exist for the application of therapy, current studies showed the antitumor effects of miRNAs. This paper reviews recent advances in miRNA mechanisms in the development of GC and the potential use of miRNAs in the diagnosis and treatment of GC.